Atherosclerosis  >>  ALD-301  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALD-301 / Nuo Therapeutics
NCT01774097: Patients With Intermittent Claudication Injected With ALDH Bright Cells

Completed
2
82
US
ALD-301, ALDH Bright Cells, ALDHbr, Aldehyde dehydrogenase-bright cells, Placebo (vehicle), Placebo, Vehicle, HSA, Human Serum Albumin
The University of Texas Health Science Center, Houston, National Heart, Lung, and Blood Institute (NHLBI), Aldagen, Center for Cell and Gene Therapy, Baylor College of Medicine
Peripheral Artery Disease, Intermittent Claudication
08/16
03/17
CLI-001, NCT00392509: ALD-301 for Critical Limb Ischemia, Randomized Trial

Completed
1/2
20
US
ALDH-br bone marrow cells vs. mononuclear bone marrow cells
Aldagen
Critical Limb Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
12/08
12/08

Download Options